Marginal Contrast Saturation‐Based Intraoperative Scoring System Predicts Objective Response to DEB ‐ TACE : Development and Validation of a CBCT ‐Derived Real‐Time Score
Cancer Medicine · 2026-06 · 15 (6)
DOI: 10.1002/cam4.72062 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Cancer Medicine, online erschienen am 22.06.2026. Verfasst von Zhongsong Gao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, Central Hospital, Tianjin University/Tianjin Third Central Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Cone-Beam Computed Tomography, Liver Neoplasms, Carcinoma, Hepatocellular, Chemoembolization, Therapeutic. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Tianjin Health Science and Technology Project, Tianjin Key Medical Discipline Construction Project, Beijing Medical Award Foundation.
Abstract (Originalsprache)
Objective
To develop and validate a simple intraoperative scoring system based on preoperative and cone‐beam CT (CBCT) features for real‐time prediction of objective response (OR) by mRECIST after DEB‐TACE in patients with HCC. Materials and Methods In this single‐center retrospective study, 274 patients (with a total of 386 HCC tumors) who underwent first‐session DEB‐TACE from 2022 to 2024 were included. CBCT was used to assess a 5‐grade marginal contrast saturation (MCS), capsule presence, vascular lake phenomenon (VLP), and other candidate imaging features. Tumor response was assessed on contrast‐enhanced CT using mRECIST. Analyses were performed on a tumor basis, with tumors assigned to development ( n = 286) and validation ( n = 100) sets by patient‐level stratified randomization (7:3). Variables associated with OR were entered into a multivariable logistic regression; β coefficients were converted into a point‐based score. Model performance was evaluated in terms of discrimination and calibration using the AUROC and the Hosmer–Lemeshow test.
Results
Most patients were male (78.8%), with a mean age of 62.5 ± 9.4 years. The median tumor diameter was 3.75 cm (interquartile range [IQR], 2.50–6.50 cm). The overall objective response rate (ORR) was 67.9% (262/386). Multivariable analysis revealed four independent predictors of OR: tumor diameter, capsule presence, VLP, and MCS grade. A 1–10‐point score achieved excellent discrimination in the development set and maintained high performance in the validation set, with an AUROC of 0.93 (95% confidence interval [CI]: 0.86–0.99, goodness‐of‐fit p = 0.46).
Conclusion
An imaging‐only, intraoperative scoring system incorporating tumor size, capsule, VLP, and MCS accurately predicts short‐term mRECIST response after DEB‐TACE, facilitating rapid decision‐making and subsequent patient management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Interventional Radiology, Central Hospital, Tianjin University/Tianjin Third Central Hospital, Tianjin, China.
- Outpatient Nursing Department, Central Hospital, Tianjin University/Tianjin Third Central Hospital, Tianjin, China.
- Department of Pathology, Central Hospital, Tianjin University/Tianjin Third Central Hospital, Tianjin, China.
- Department of Medical Imaging, Central Hospital, Tianjin University/Tianjin Third Central Hospital, Tianjin, China.
ORCID-Profile: Qi Xin, Kefeng Jia
Förderung
- Tianjin Health Science and Technology Project
- Tianjin Key Medical Discipline Construction Project
- Beijing Medical Award Foundation
Zitieren
APA
Gao, Z., Li, B., Feng, B., Sun, C., Zang, Y., Zhang, X., Wang, Y., Xin, Q., Jia, K., & Lyu, R. (2026). Marginal Contrast Saturation‐Based Intraoperative Scoring System Predicts Objective Response to DEB ‐ TACE : Development and Validation of a CBCT ‐Derived Real‐Time Score. Cancer Medicine, 15(6). https://doi.org/10.1002/cam4.72062
Vancouver
Gao Z, Li B, Feng B, Sun C, Zang Y, Zhang X, et al. Marginal Contrast Saturation‐Based Intraoperative Scoring System Predicts Objective Response to DEB ‐ TACE : Development and Validation of a CBCT ‐Derived Real‐Time Score. Cancer Medicine. 2026;15(6). doi:10.1002/cam4.72062
BibTeX
@article{Gao2026,
author = {Gao, Zhongsong and Li, Bo and Feng, Bo and Sun, Cheng and Zang, Ying and Zhang, Xin and Wang, Yongmei and Xin, Qi and Jia, Kefeng and Lyu, Rong},
title = {Marginal Contrast Saturation‐Based Intraoperative Scoring System Predicts Objective Response to DEB ‐ TACE : Development and Validation of a CBCT ‐Derived Real‐Time Score},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {6},
doi = {10.1002/cam4.72062}
}
EUVIMED